Christopher M Parry Selected Research

Ofloxacin (Ofloxacine)

1/2022	Quantitative bacterial counts in the bone marrow of Vietnamese patients with typhoid fever.
1/2021	Bactericidal activities and post-antibiotic effects of ofloxacin and ceftriaxone against drug-resistant Salmonella enterica serovar Typhi.
6/2011	The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy.
12/2010	Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.
3/2007	Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever.
3/2005	Comparative trial of short-course ofloxacin for uncomplicated typhoid fever in Vietnamese children.
7/2004	The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher M Parry Research Topics

Disease

32	Typhoid Fever (Typhoid) 01/2021 - 03/2004
19	Infections 01/2021 - 04/2003
6	Fever (Fevers) 01/2022 - 03/2004
4	Sepsis (Septicemia) 01/2022 - 11/2011
3	Tuberculosis (Tuberculoses) 01/2020 - 11/2004
3	Salmonella Infections (Salmonellosis) 10/2015 - 10/2003
2	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2020 - 06/2013
2	Pneumonia (Pneumonitis) 01/2020 - 11/2004
2	Bacillary Dysentery (Shigellosis) 01/2018 - 03/2016
2	Dengue (Dengue Fever) 10/2016 - 02/2015
2	Ventilator-Associated Pneumonia 10/2015 - 10/2014
2	Tetanus 04/2015 - 11/2004
2	Pneumococcal Infections 02/2014 - 07/2013
2	Meningitis 06/2011 - 11/2002
1	Asthma (Bronchial Asthma) 05/2022
1	Drug-Related Side Effects and Adverse Reactions 04/2022
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 04/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2022
1	Hepatomegaly 01/2022
1	Splenomegaly 01/2022
1	Parasitemia 12/2020
1	Malaria 12/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Pharyngitis (Sore Throat) 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Tonsillitis 01/2020
1	Urinary Tract Infections (Urinary Tract Infection) 01/2020
1	Pyomyositis 01/2019
1	Bacteremia 01/2018
1	Granuloma 01/2018
1	Abscess 08/2017
1	Wound Infection (Wound Infections) 08/2017
1	Peritonitis 08/2017
1	Inflammation (Inflammations) 07/2017
1	Giardiasis 01/2016
1	Leukocytosis (Pleocytosis) 04/2015
1	Shock 04/2015
1	Leptospirosis 01/2015
1	Ophthalmia Neonatorum 11/2014
1	Communicable Diseases (Infectious Diseases) 10/2014

Drug/Important Bio-Agent (IBA)

9	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 11/2002
8	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 07/2004
8	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2019 - 10/2008
7	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2022 - 07/2004
7	Immunoglobulin M (IgM)IBA 11/2018 - 02/2012
5	FluoroquinolonesIBA 12/2019 - 10/2003
5	Pharmaceutical PreparationsIBA 11/2018 - 10/2003
4	AntigensIBA 01/2017 - 02/2015
4	VaccinesIBA 06/2015 - 11/2004
3	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2021 - 07/2004
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 04/2015
3	EnzymesIBA 06/2013 - 12/2004
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 12/2004
2	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2022 - 10/2003
2	Cefixime (Suprax)FDA Link 01/2021 - 07/2004
2	Gatifloxacin (Zymar)FDA Link 03/2016 - 10/2008
2	Immunoglobulin G (IgG)IBA 10/2015 - 09/2005
2	AntibodiesIBA 10/2015 - 08/2008
2	Carbapenems (Carbapenem Antibiotics)IBA 10/2015 - 10/2014
2	Anti-Infective Agents (Microbicides)IBA 06/2015 - 11/2002
2	Sulfamethoxazole FDA LinkGeneric 12/2012 - 11/2004
2	Trimethoprim (Proloprim)FDA LinkGeneric 12/2012 - 11/2004
2	Penicillins (Penicillin)FDA Link 06/2011 - 11/2002
2	Nalidixic Acid FDA Link 03/2007 - 07/2004
2	QuinolonesIBA 07/2006 - 10/2003
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022
1	Mesalamine (Mesalazine)FDA LinkGeneric 04/2022
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2022
1	ArtesunateIBA 12/2020
1	Volatile Fatty AcidsIBA 07/2020
1	lipoarabinomannan (LAM)IBA 01/2020
1	beta-Lactamases (beta-Lactamase)IBA 01/2020
1	Leukocidins (Leukocidin)IBA 01/2019
1	Third Generation CephalosporinsIBA 01/2018
1	Cloxacillin (Tegopen)FDA Link 08/2017
1	CytokinesIBA 07/2017
1	InterferonsIBA 07/2017
1	Serine Proteases (Serine Protease)IBA 07/2017
1	Granzymes (Granzyme)IBA 07/2017
1	LatexIBA 01/2017
1	Polysaccharides (Glycans)IBA 01/2017
1	Soaps (Soap)IBA 01/2016
1	Conjugate VaccinesIBA 01/2016
1	O Antigens (O Antigen)IBA 10/2015
1	Colistin (Coly-Mycin)FDA Link 10/2015
1	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 06/2015
1	EndotoxinsIBA 04/2015
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 04/2015
1	Toll-Like Receptor 4IBA 04/2015
1	Staphylococcal Protein A (Protein A)IBA 01/2015
1	Immunoglobulins (Immunoglobulin)IBA 01/2015
1	HLA-DRB1*04 antigenIBA 12/2014
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2014
1	DNA (Deoxyribonucleic Acid)IBA 11/2014

Therapy/Procedure

4	Therapeutics 12/2019 - 11/2002
3	Critical Care (Surgical Intensive Care) 04/2015 - 11/2004
2	Laparotomy 01/2018 - 08/2017
2	Duration of Therapy 05/2016 - 06/2011
1	Treatment Delay 01/2020
1	Drug Therapy (Chemotherapy) 01/2018